Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Michal Witkowski"'
Autor:
Michal Witkowski, Søren Ilsøe Moreno, João Fernandes, Pierre Johansen, Margarida Augusto, Sunita Nair
Publikováno v:
PharmacoEconomics. 40:751-776
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc15bb0b2dabd180272ae60aa6911378
https://doi.org/10.1007/s40273-022-01140-y
https://doi.org/10.1007/s40273-022-01140-y
Publikováno v:
Diabetes Therapy
Introduction Once-weekly semaglutide is a new glucagon-like peptide-1 (GLP-1) analogue administered at a 1.0 or 0.5 mg dose. As head-to-head trials assessing once-weekly semaglutide as an add-on to 1–2 oral anti-diabetic drugs (OADs) vs other GLP-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed520d8c5a82f47fc7ba3ab69f5ea852
https://doi.org/10.1007/s13300-018-0424-2
https://doi.org/10.1007/s13300-018-0424-2
Publikováno v:
Diabetes Therapy
Introduction Once-weekly semaglutide is a glucagon-like peptide-1 (GLP-1) analogue that is currently available as 1.0 mg and 0.5 mg dose for the treatment of type 2 diabetes (T2D). Currently, no head-to-head trial investigating once-weekly semaglutid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fca14a34f1c240415291106cb9e388fd
http://europepmc.org/articles/PMC5984931
http://europepmc.org/articles/PMC5984931
Publikováno v:
International Journal of Cardiology. 227:583-588
Atrial fibrillation is the most common chronic arrhythmia. Due to diagnostic difficulties, the exact prevalence of silent atrial fibrillation is not precisely defined.The main aim of the present study was to assess the prevalence of asymptomatic atri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b0ebbb8a7d40bf9f9a2d55964b13c0
https://doi.org/10.1016/j.ijcard.2016.10.097
https://doi.org/10.1016/j.ijcard.2016.10.097
Publikováno v:
Diabetes Therapy
Introduction Semaglutide once-weekly (QW) is a novel glucagon-like peptide-1 (GLP-1) analogue administered at a 0.5 or 1.0 mg dose. In the absence of head-to-head trials between semaglutide QW and other GLP-1 receptor agonists (GLP-1 RAs) in a Japane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4be966ebb39f8cc3ebcb52a5194ef3b
https://pubmed.ncbi.nlm.nih.gov/29574633
https://pubmed.ncbi.nlm.nih.gov/29574633
Publikováno v:
Value in Health. 19:A665-A666
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4680e5b2107863b5b1e4af6e9577a5ea
https://doi.org/10.1016/j.jval.2016.09.1835
https://doi.org/10.1016/j.jval.2016.09.1835
Publikováno v:
Value in Health. 17(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5c619676e207a416758fb90f05defda
Autor:
Lorenza Pastorino, Giovanni Ponti, Cristel Ruini, Giampiero Girolomoni, Paola Ghiorzo, Aldo Tomasi, Giovanni Pellacani, Sabina Nasti, Francesca Farnetani, Alexander Michal Witkowski, Pietro Loschi, Giovanna Bianchi-Scarrà
ABSTRACT: Brooke–Spiegler syndrome is a hereditary disorder characterized by a predisposition to the development of skin appendage neoplasms and the major and minor salivary glands neoplasms. The role of the CYLD mutation in visceral neoplasms is s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e66454b0ac22fa4bc89a03bc9714c8
http://hdl.handle.net/11573/1483602
http://hdl.handle.net/11573/1483602
Autor:
N Aldhouse, Michal Witkowski
Publikováno v:
Value in Health. 18(7):A721-A722
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ece8ab1f9919597f900aa35c5b72722